Kyle Apley advances biopharmaceutical discovery and biomanufacturing, with an issued patent on conjugates that induce B‑cell anergy. Publications span biologics design-to-manufacture, protein engineering, glycoengineering, antigen‑specific immunomodulation, and drug delivery/formulation.